Q&A: Monoclonal Antibodies for COVID-19
The IDSA recommends that antibody therapy should be administered to patients with mild to moderate COVID-19 at high risk for progression to severe disease.
COVID19 Vaccine
ACIP: Benefits of mRNA COVID-19 Vaccines Outweigh Risks for ≥12s
After reviewing evidence, including data on risks for myocarditis, vaccination benefits outweigh risks for all populations
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1% of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Myocarditis-Like Illness Reported After COVID-19 Vaccination
Case series describes 7 cases in males younger than 40 years; all patients’ symptoms were resolved by the time of hospital discharge
COVID-19 Vaccines Do Not Interfere With Male Fertility
No significant decreases seen in any sperm parameters following 2 doses of an mRNA COVID-19 vaccine
Second COVID-19 Vaccine Dose Missed by More Than 10 Percent of Americans
Adults younger than 30 most likely to have missed second dose, with nearly 12 percent outside of the 42-day allowable window
Disparities in COVID-19 Vaccination ID’d Among Health Employees
At MetroHealth System, probability of vaccination up for employees older than 44 years, men, Whites, and Asians
Third COVID-19 Vaccine Dose Shows Variable Efficacy in Solid Organ Transplant Recipients
In a case series, SARS-CoV-2 antibody titers increased after the third dose in a third of patients who previously had no response to vaccination.
AMA: 96 Percent of Physicians Fully Vaccinated Against COVID-19
No significant differences seen in physician vaccination rates across demographic groups, including region, gender, age
- Loading...
Loading...
Next post in Practice Management
Loading... 
Loading...